Journals / Retina-Vitreus / 2002 / Cilt: 10 - Sayı: 3

Pneumatic displacement of the submacular hemorrhages

Submakuler hemorajide vitreus içi gaz tamponadı ile yer değiştirme

Pages
240–248
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although our series was not large enough, the anatomic and functional results of AMD group were better than MA group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the results of the pneumatic displacement of the submacular hemorrhage caused by exudative age related macular degeneration (AMD) or retinal arterial macroaneurism (MA).
📊
Key Findings & Data:Methods: Intravitreal injection of 0.4cc sulfur hexafluoride (SF6) followed by face down position for 3 days was performed in six eyes of six patients (4 males, 2 females) with submacular hemorrhage due to the exudative AMD (3 patients) and MA (3 patients).
💡
Conclusion & Impact:Although our series was not large enough, the anatomic and functional results of AMD group were better than MA group.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Tedavi sonucu · Maküler dejenerasyon · Ameliyat sonrası dönem

Abstract

Purpose: To evaluate the results of the pneumatic displacement of the submacular hemorrhage caused by exudative age related macular degeneration (AMD) or retinal arterial macroaneurism (MA). Methods: Intravitreal injection of 0.4cc sulfur hexafluoride (SF6) followed by face down position for 3 days was performed in six eyes of six patients (4 males, 2 females) with submacular hemorrhage due to the exudative AMD (3 patients) and MA (3 patients). The age of the patients was between 56 and 85 years (mean age, 72.8 years). The duration between the subretinal hemorrhage and the treatment ranged from 3 to 21 days (mean, 9 days). The size of the hemorrage was between 3 and 7 disc areas (DA) (mean, 5.3DA). Results: Best corrected visual acuity (BCVA) before the treatment was between hand motions and 0.2. No complication was seen during intravitreal injection of SF6 or in the postoperative period. Follow-up ranged from 3 to 10 months after treatment (mean, 6.6 months). Displacement of the submacular hemorrhage after the treatment occured completely in all patients with AMD and in one patient with MA, partially in one patient with MA; no displacement was obtained in one patient with MA. After treatment, BCVA was between counting fingers from 1m. and 0.4. After the gas injection, BCVA improved in all patients with AMD, and only in one patient with MA. Conclusion: If we consider the poor prognosis of submacular hemorrhage in patients with AMD or retinal arterial MA, pneumatic displacement of the submacular hemorrhage may be an effective method because of its application facility, low complication rate and good anatomic and functional results. Although our series was not large enough, the anatomic and functional results of AMD group were better than MA group.

Özet

Amaç: Eksüdatif tipte yaşa bağlı makula dejeneresansı'na (YBMD) ya da retinal arteriyel makroanevrizma'ya (MA) bağlı submakuler hemoraji olgularında vitreus içine gaz uygulaması ile hemorajinin yer değişimi sonuçlarının araştırılması. Yöntem: Yaşları 56 ile 85 arasında değişen (ort. 72.8 yaş), 3'ü YBMD, diğer 3'ü MA'ya bağlı submakuler hemoraji gelişmiş, dördü erkek, ikisi kadın toplam 6 hastanın 6 gözüne, hemorajiyi dağıtmak amacıyla vitreus içine 0.4mlt. sülfür heksaflorür (SF6) enjekte edildi. İşlemin ardından hastalara 3 gün süreyle yüzükoyun yatış pozisyonu uygulandı. Hemoraji oluşumu ile tedavi arasındaki süre 3 gün ila 21 gün arasında olup (ort.9 gün), hemoraji alanı 3 ila 7 disk alanı (DA) arasında değişmekteydi (ort. 5.3 DA). Bulgular: Tedavi öncesi düzeltilmiş görme keskinlikleri, el hareketleri ile 0.2 arasında idi. Vitreus içine SF6 uygulaması sırasında ve postoperatif dönemde bir komplikasyon ile karşılaşılmadı. Takip süreleri, 3 ila 10 ay arasında değişmekteydi (ort. 6.6ay). Tedavi sonrası submakuler hemorajinin makula bölgesinden dağılımı, YBMD tanılı 3 hastanın hepsinde tam, MA tanılı 1 hastada tam, 1 hastada kısmi olarak gerçekleşirken, 1 hastada anatomik başarı elde edilemedi. Tedavi sonrası düzeltilmiş görme keskinliği, 1m.den parmak sayma (1m PS) ile 0.4 arasında değişmekte olup, YBMD tanılı 3 hastada da artarken, MA tanılı yalnızca 1 hastada artış izlendi. Sonuç: YBMD ve retinal MA'ya bağlı gelişen submakuler hemorajinin kötü prognozu göz önüne alındığında, submakuler hemorajinin vitreus içine verilen gaz tamponadı ile yer değiştirilmesi, uygulama kolaylığı, düşük komplikasyon oranı, kısa izlem süresindeki anatomik ve görsel sonuçları açısından etkili bir tedavi yöntemi olarak kabul edilebilir. Ayrıca, hasta sayısı fazla olmamakla birlikte, YBMD grubunda elde edilen anatomik ve fonksiyonel sonuçların, MA grubuna göre daha iyi olduğu görüldü.

🔖

Cite This Article

ERAKGÜN, T., MENTEŞ, J., AKKIN, C., AFRASHI, F. (2002). Pneumatic displacement of the submacular hemorrhages. Retina-Vitreus, Cilt: 10 - Sayı: 3, 240–248. https://ajindex.com/articles/307814

References (14)

  1. Bennett AR, Folk JC, Blodi CF, Klugman M. Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol 1990: 109:33-37
  2. Berrocal MH, Lewis ML, Flynn HW. Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol 1996; 122: 486-493
  3. Avery RL, Fekrat S, Hawkins BS, Bressler NM. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina 1996; 16: 183-189. n 4. Scupola A, Coscas G, Soubrane G, Balestrazzi E. Natural history of subretinal hemorrhage in age-related macular degeneration. Ophthalmologica 1999; 213: 97-102
  4. Lewis H. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 1994; 118: 559-68
  5. Kamei M, Tano Y, Maeno T, et al. Surgical removal of submacular hemorrhage using tissue pfasminogen activator and perfluorocarbon liquid. Am J Ophthalmol 1996; 121: 267-275
  6. Claes C, Zivojnovic R. Efficacy of tissue plasminogen activator (t-PA) in subretinal hemorrhage removal. Bull Soc Belge Ophtalmol 1996-261: 115-118
  7. Lim Jl, Drews-Botsch C, Sternberg P Jr, et al. Submacular hemorrhage removal. Ophthalmology 1995; 102: 1393-1399
  8. Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol 1982; 94: 762-773. 10. el Baba F, Jarrett WH II, Harbin TS Jr, et al. Massive hemorrhage complicating age-related macular degeneration. Clinicopathologic correlation and role of anticoagulants. Ophthalmology 1986; 93: 1581-1592
  9. Wade EW, Flynn AW Jr, Losen KR et al. Subretinal hemorrhage management by pars plana vitredtomy and internai drainage. Arch Ophthalmol 1990; 108: 973-978
  10. Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreal tPA injection and pneumatic displacement. Ophthalmology 1999; 106: 1900-1907
  11. Hesse L, Schmidt J, Kroll P. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefe's Arch Clin Exp Ophthalmol 1999; 237: 273-277
  12. Meier P, Zeumer C, Jochmann C, Wiedemann P. Management of submacular hemorrhage by tissue plasminogen activator and SF6 gas injection. Ophthalmologue 1999; 96: 643-647
  13. Johnson MW, Olsen KR, Hernandez E, et al. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit. Arch Ophthalmol 1990; 108: 259-263
  14. Kokame GT. Vitreous hemorrhage after intravitreal tissue plasminogen activator (t-PA) and pneumatic disp